First Light Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

First Light Asset Management’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,432,208	Closed	-$146M	–	82
2023 Q2	$146M	Sell	1,432,208 -154,720	-10%	-$14.6M	11.45%	1
2023 Q1	$144M	Sell	1,586,928 -475,525	-23%	-$27.9M	12.99%	1
2022 Q4	$78.4M	Buy	2,062,453 +1,007,468	+95%	+$34.7M	7.27%	3
2022 Q3	$26.5M	Buy	+1,054,985	New	+$29.2M	2.68%	12

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

First Light Asset Management's RETA Position: Q3 2023 in Review

First Light Asset Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 1,432,208 shares — an estimated $146M sold.

First Light Asset Management first reported a position in RETA in Q3 2022 and held it in 4 quarters. The position peaked at $146M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

First Light Asset Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
First Light Asset Management sold 1,432,208 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $146M.
First Light Asset Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2022 and held it in 4 quarters.
First Light Asset Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $146M in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on First Light Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.